Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C, Claxton D, Donato M, Bruton J, Cohen A, Davis M, Andersson BS, Anderlini P, Gajewski J, Kornblau S, Andreeff M, Przepiorka D, Ueno NT, Molldrem J, Champlin R.
Giralt S, et al. Among authors: davis m.
Blood. 2001 Feb 1;97(3):631-7. doi: 10.1182/blood.v97.3.631.
Blood. 2001.
PMID: 11157478
Free article.
Clinical Trial.